Paper
RSC Advances
strategy presents a clear advantage over those using peroxides,
9 E. Negishi, Acc. Chem. Res., 1982, 15, 340–348.
since it is not easy to control oxidation processes involving the 10 C. B. Ziegler and R. F. Heck, J. Org. Chem., 1978, 34, 2941–
latter reagents.
2946.
´
11 R. Chinchilla and C. Najera, Chem. Rev., 2007, 107, 874–922.
12 Q. Yu, L. Hu, Y. Wang, S. Zheng and J. Huang, Angew. Chem.,
Int. Ed., 2015, 54, 15284–15288.
Conflicts of interest
There are no conicts to declare.
13 (a) T. Zhang, X. Qi, S. Liu, R. Bai, C. Liu and Y. Lan, Chem.–
Eur. J., 2017, 23, 2690–2699; (b) P. Zhang, L. Hong, G. Li and
R. Wang, Adv. Synth. Catal., 2015, 357, 345–349.
Acknowledgements
´
´
14 (a) F. Mendoza, R. Ruız-guerrero, C. Hernandez-Fuentes,
P. Molina, M. Norzagaray-Campos and E. Reguere,
Tetrahedron Lett., 2016, 57, 5644–5648; (b) S. M. Islam,
R. A. Molla, A. S. Roy, K. Ghosh, N. Salam, M. A. Iqubal
and K. Tuhina, J. Organomet. Chem., 2014, 761, 169–178.
We are grateful to CONACyT (CB-2013/220836) for nancial
support. We acknowledge the facilities of the DCNyE, the
Chemistry Department, and the National Laboratory UG-
CONACyT (LACAPFEM) of the University of Guanajuato for
full characterization. We thank CONACyT for fellowships to 15 (a) W. Liu, J. Chen, R. Jin, D. Xu, Y. Li, F. Ba, G. Gu, Y. Kuang
´
Y.$S., P. D. N., V. R. and K. A. J. O. We also thank Dr Ramon
Zapata for providing samples of Naproxen and Paracetamol
and L. Yera for kind contribution.
and H. Guo, Org. Chem. Front., 2016, 3, 852–855; (b) X.-E. Li,
W. Wu, X.-H. Fan and L.-M. Yang, RSC Adv., 2013, 3, 12091–
12095.
16 X. Sun, G. Shan, Y. Sun and Y. Rao, Angew. Chem., Int. Ed.,
2013, 52, 4440–4444.
17 F. Mo, J. M. Yan, D. Qiu, F. Li, Y. Zhang and J. Wang, Angew.
Chem., Int. Ed., 2010, 49, 2028–2032.
Notes and references
1 Organic Bromine and Iodine Compounds, The Handbook of
Environmental Chemistry, ed. Nelson A. H., Springer, Berlin, 18 For NBS-organocatalyst see:Y. Xiong, F. Tan and Y.-Y. Yeung,
2003, vol. 3R.
Org. Lett., 2017, 19, 4243–4246.
2 M. Tang and Z. Bao, Chem. Mater., 2011, 23, 446–455.
19 (a) For NBS in ionic liquid, see:S. R. Pingali, M. Madhav and
B. S. Jursic, Tetrahedron Lett., 2010, 51, 1383–1385; (b) For Br2
in ionic liquid, see:Y.-L. Ren, B. Wang, X.-E. Tian, S. Zhao
and J. Wang, Tetrahedron Lett., 2010, 56, 6452–6455.
20 For NBS-TMSCl see:T. Mainbukaew, B. Thongsornkleeb,
J. Tummatorn, A. Bunrit and S. Ruchirawat, Synlett, 2014,
25, 1769–1775.
¨
3 (a) C. Wagner, M. El Omari and G. M. Konig, J. Nat. Prod.,
2009, 72, 540–543; (b) C. S. Neumann, D. G. Fujimori and
C. T. Walsh, Chem. Biol., 2008, 15, 99–109; (c)
K. Benkendroff, Mar. Drugs, 2013, 11, 1370–1398.
4 (a) G. W. Gribble, Chem. Soc. Rev., 1999, 28, 335–346; (b) For
synthesis of 4-isocymobarbatol see: S. A. Snyder, D. S. Treitler
and A. P. Brucks, J. Am. Chem. Soc., 2010, 132, 14303–14314; 21 For Br2-supercritical CO2 see:T. Delgado-Abad, M.-J. Ferrer,
´
J. Reig-Lopez, R. Mello, R. Acerete, G. Asensio and
(c) For isolation of vidalol B see:N. Sitachitta and J. Gerwick,
J. Nat. Prod., 1998, 61, 681–684; (d) For isolation of
´
˜
´
M. E. Gonzalez-Nunez, RSC Adv., 2014, 4, 51016–51021.
amathamide G see:H. Kang and W. Fenical, Tetrahedron 22 For Br2 on Fe2O3–zeolites see:Y. Nishina and K. Takami,
Lett., 1997, 38, 941–944; (e) For total synthesis of
Green Chem., 2012, 14, 2380–2383.
(ꢁ)-chartelline see:P. S. Baran, R. A. Shenvi and 23 D. Liang, X. Li, C. Wang, Q. Dong, B. Wang and H. Wang,
C. A. Mistos, Angew. Chem., Int. Ed., 2005, 44, 3714–3717; Tetrahedron Lett., 2016, 57, 5390–5394.
(f) P. S. Baran and R. A. Shenvi, J. Am. Chem. Soc., 2006, 24 A. Podgorsek, S. Stavber, M. Zupan and J. Iskra, Tetrahedron,
C
ˇ
128, 14028–14029; (g) for gymnochrome A see:B. D. Morris
and M. R. Prinsep, J. Org. Chem., 1998, 63, 9545–9547.
5 (a) M. Gobinath, N. Subramanian and V. Alagarsamy, J. Saudi
2009, 65, 4429–4439.
25 S. Song, X. Sun, X. Li, Y. Yuan and N. Jiao, Org. Lett., 2015, 17,
2886–2889.
Chem. Soc., 2015, 19, 282–286; (b) A. Jain, L. S. Duvvuri, 26 J. Hou, Z. Li, X.-D. Xia and Z.-Q. Liu, Synth. Commun., 2014,
S. Farah, N. Beyth, A. J. Domb and W. Khan, Adv.
44, 181–187.
Healthcare Mater., 2014, 3, 1969–1985; (c) J. Wang, 27 D. C. Braddock, G. Cansell and S. A. Hermitage, Synlett,
´
´
˜
M. Sanchez-Rosello, J. L. Acena, C. Del Pozo,
2004, 3, 461–464.
A. E. Sorochinsky, S. Fustero, V. A. Soloshonok and H. Liu, 28 Z. Zhou and H. He, Synthesis, 2011, 2, 207–209.
Chem. Rev., 2014, 114, 2432–2506; (d) A. S. Christophersen, 29 P. A. Evans and T. A. Brandt, J. Org. Chem., 1997, 62, 5321–
Toxicol. Lett., 2000, 127, 112–113; (e) For synthesis of
5326.
´
JHU75575 see:S. R. Donohue, R. F. Dannals, C. Halldin and 30 P. D. Nahide, V. Ramadoss, K. Juarez-Ornelas, Y. Satkar,
V. W. Pike, J. Med. Chem., 2011, 54, 2961–2970.
6 F. Hu, M. Patel, F. Luo, C. Flach, R. Mendelson, E. Garfunkel,
H. He and M. Szostak, J. Am. Chem. Soc., 2015, 137, 14473–
14480.
R. Ortiz-Alvarado, J. M. J. Cervera-Villanueva, A. J. Alonso-
´
Castro, J. R. Zapata-Morales, M. A. Ramırez-Morales,
´
A. Ruiz-Padilla, M. A. Deveze-Alvarez and C. R. Solorio-
Alvarado, Eur. J. Org. Chem., 2018, 485–493.
7 N. Miyaura and A. Suzuki, Chem. Rev., 1995, 95, 2457–2483. 31 (a) An extensive search in the literature reveals that this
8 J. H. Li, Y. Liang and Y. X. Xie, Tetrahedron, 2005, 61, 7289–
7293.
described route (O-functionalization and bromination) is
opposite that most commonly used for the synthesis of 29–
This journal is © The Royal Society of Chemistry 2018
RSC Adv., 2018, 8, 17806–17812 | 17811